Pharma/Life Sciences
Europe Guide 2024 : France
Band 1
Contact number
+33 1 5757 8080About
Provided by Dechert LLP
Dechert’s life sciences team in France represents companies ranging from multinational giants to emerging companies involving all aspects of the life sciences industry, including pharmaceuticals, biotechnology, drug discovery, genomics, biopharmaceuticals, diagnostics, medical devices and healthcare. We also assist with investment funds in life sciences investments.
With life sciences lawyers in the U.S., Europe, Asia and the Middle East, we are well-positioned to handle the most complex cross-border matters for our clients. Our representation of both large pharmaceutical companies as well as smaller and mid-size biotechnology and specialty pharmaceutical companies is a distinguishing feature of our firm, and our Paris office allows us to structure and negotiate transactions from the perspective of both parties.
Our extensive experience includes:
- M&A and private equity transactions
- Reorganizations and international tax planning
- Antitrust/competition
- Pharmaceutical contractual and regulatory advice
- Corporate law
- Licensing and corporate partnering
- Strategic IP counseling/complex IP litigation
- Litigation and international arbitration
- Corporate finance and capital markets
Chambers Review
Dechert is a top firm regularly handling corporate and competition matters in the sector, advising on M&A transactions and related merger filing and control aspects. The team is also experienced in providing regulatory advice on the pricing of medical devices and medicines, with further expertise in abuse of dominant position cases. The law firm offers assistance with cross-border matters, notably across Europe, the USA and Asia.
Work Highlights
- Dechert represented Roche before the Paris Court of Appeal in the challenge against the French Competition Authority’s decision for alleged abused of collective dominant position.
Strengths
Provided by Chambers
"Dechert demonstrated agility by adapting to the complex case and never lost sight of the primary objective, which was for the client to win the deal in the end."
"The firm has a very skilled team that is experienced in handling many cases for pharmaceutical and medtech companies in France."
"Dechert has a very competent and very responsive team of lawyers."
"Dechert demonstrated agility by adapting to the complex case and never lost sight of the primary objective, which was for the client to win the deal in the end."
"The firm has a very skilled team that is experienced in handling many cases for pharmaceutical and medtech companies in France."
"Dechert has a very competent and very responsive team of lawyers."
Notable Practitioners
Alain Decombe maintains an eminent reputation for his advice on corporate transactions in the life sciences sector. He is adept at assisting with cross-border mandates.
"Alain is important in the pharma ecosystem in France."
Mélanie Thill-Tayara is a leading practitioner with significant expertise in abuse of dominant position and merger control cases. She represents multinational pharmaceutical companies before French and European competition authorities.
Sophie Pelé is noted for her expertise on regulatory issues and assists with both domestic and cross-border mandates.
"Sophie Pelé is a highly skilled regulatory lawyer who knows very well the challenges of the healthcare market."
"Sophie has an excellent knowledge of the pharmaceutical industry environment, particularly on regulatory matters."